Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| WDR1 | O75083 | WD repeat-containing protein 1 (Actin-interacting protein 1) (AIP1) (NORI-1) | Disease related genesEssential proteinsHuman disease related genes | Fusion and delivery mediationImmune mediation | 49 | 0.63 | ||||
| STRN3 | Q13033 | Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen) | Plasma proteinsPredicted intracellular proteins | Other mediation | 36 | 0.63 | ||||
| TSN15 | O95858 | Tetraspanin-15 (Tspan-15) (Tetraspan NET-7) (Transmembrane 4 superfamily member 15) | Predicted membrane proteinsTransporters | 4 | Fusion and delivery mediationMetabolism mediation | 32 | 0.63 | |||
| SPP2A | Q8TCT8 | Signal peptide peptidase-like 2A (SPP-like 2A) (SPPL2a) (EC 3.4.23.-) (Intramembrane protease 3) (IMP-3) (Presenilin-like protein 2) | Disease related genesEnzymesHuman disease related genes | 9 | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 27 | 0.63 | |||
| VANG1 | Q8TAA9 | Vang-like protein 1 (Loop-tail protein 2 homolog) (LPP2) (Strabismus 2) (Van Gogh-like protein 1) | Disease related genesHuman disease related genesPotential drug targets | 4 | Receptor-signaling mediation | 26 | 0.63 | |||
| LSAMP | Q13449 | Limbic system-associated membrane protein (LSAMP) (IgLON family member 3) | Metabolism mediation | 25 | 0.63 | |||||
| WASF2 | Q9Y6W5 | Actin-binding protein WASF2 (Protein WAVE-2) (Verprolin homology domain-containing protein 2) (Wiskott-Aldrich syndrome protein family member 2) (WASP family protein member 2) | Predicted intracellular proteins | Clinical-translation mediationFusion and delivery mediationImmune mediation | 24 | 0.63 | ||||
| MAP4 | P27816 | Microtubule-associated protein 4 (MAP-4) | FDA approved drug targetsPlasma proteinsPredicted intracellular proteins | Clinical-translation mediation | 21 | 0.63 | ||||
| ANXA1 | P04083 | Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35) [Cleaved into: Annexin Ac2-26] | Cancer-related genesFDA approved drug targetsPlasma proteins | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 10 | 0.63 | ||||
| ARHGI | Q6ZSZ5 | Rho guanine nucleotide exchange factor 18 (114 kDa Rho-specific guanine nucleotide exchange factor) (p114-Rho-GEF) (p114RhoGEF) (Septin-associated RhoGEF) (SA-RhoGEF) | Disease related genesHuman disease related genesPredicted intracellular proteins | Retinitis pigmentosa | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 10 | 0.63 |